{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:45:09Z","timestamp":1792251909680,"version":"4.4.0"},"reference-count":29,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.28204","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T07:32:21Z","timestamp":1633591941000},"page":"e2128204","source":"Crossref","is-referenced-by-count":43,"title":["Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome"],"prefix":"10.1001","volume":"4","author":[{"given":"Joseph","family":"Jankovic","sequence":"first","affiliation":[{"name":"Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Coffey","sequence":"additional","affiliation":[{"name":"University of Miami Miller School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel O.","family":"Claassen","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joohi","family":"Jimenez-Shahed","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J.","family":"Gertz","sequence":"additional","affiliation":[{"name":"Nuvelution TS Pharma Inc., San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Garofalo","sequence":"additional","affiliation":[{"name":"Nuvelution TS Pharma Inc., San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Stamler","sequence":"additional","affiliation":[{"name":"Teva Pharmaceuticals, La Jolla, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Wieman","sequence":"additional","affiliation":[{"name":"Teva Pharmaceuticals, West Chester, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha-Matti","family":"Savola","sequence":"additional","affiliation":[{"name":"Teva Pharmaceuticals, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Forrest","family":"Gordon","sequence":"additional","affiliation":[{"name":"Teva Pharmaceuticals, West Chester, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Alexander","sequence":"additional","affiliation":[{"name":"Teva Pharmaceuticals, West Chester, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadas","family":"Barkay","sequence":"additional","affiliation":[{"name":"Teva Pharmaceuticals, Netanya, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eran","family":"Harary","sequence":"additional","affiliation":[{"name":"Teva Pharmaceuticals, Netanya, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,10,5]]},"reference":[{"issue":"10","key":"zoi210819r1","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/jpc.2018.54.issue-10","article-title":"Tics and Tourette syndrome.","volume":"54","author":"Efron","year":"2018","journal-title":"J Paediatr Child Health"},{"key":"zoi210819r2","doi-asserted-by":"publisher","first-page":"16097","DOI":"10.1038\/nrdp.2016.97","article-title":"Gilles de la Tourette syndrome.","volume":"3","author":"Robertson","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"zoi210819r3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jocrd.2014.03.005","article-title":"Progress in research on Tourette syndrome.","volume":"3","author":"Black","year":"2014","journal-title":"J Obsessive Compuls Relat Disord"},{"issue":"3","key":"zoi210819r4","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.psychres.2013.09.021","article-title":"A cluster analysis of tic symptoms in children and adults with Tourette syndrome: clinical correlates and treatment outcome.","volume":"210","author":"McGuire","year":"2013","journal-title":"Psychiatry Res"},{"issue":"19","key":"zoi210819r5","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1212\/WNL.0000000000007466","article-title":"Practice guideline recommendations summary: treatment of tics in people with Tourette syndrome and chronic tic disorders.","volume":"92","author":"Pringsheim","year":"2019","journal-title":"Neurology"},{"issue":"5","key":"zoi210819r6","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00702-019-02105-w","article-title":"Treatment of tics associated with Tourette syndrome.","volume":"127","author":"Jankovic","year":"2020","journal-title":"J Neural Transm (Vienna)"},{"issue":"4","key":"zoi210819r7","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s13311-020-00914-6","article-title":"Current management of tics and tourette syndrome: behavioral, pharmacologic, and surgical treatments.","volume":"17","author":"Billnitzer","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"3","key":"zoi210819r8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/NRL.0000000000000218","article-title":"Progress in pharmacological and surgical management of Tourette syndrome and other chronic tic disorders.","volume":"24","author":"Pandey","year":"2019","journal-title":"Neurologist"},{"issue":"19","key":"zoi210819r9","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1212\/WNL.0000000000007467","article-title":"Comprehensive systematic review summary: treatment of tics in people with Tourette syndrome and chronic tic disorders.","volume":"92","author":"Pringsheim","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"zoi210819r10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40263-017-0486-0","article-title":"Current approaches and new developments in the pharmacological management of Tourette syndrome.","volume":"32","author":"Quezada","year":"2018","journal-title":"CNS Drugs"},{"issue":"18","key":"zoi210819r11","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1080\/14656566.2016.1258063","article-title":"Dopamine depleters in the treatment of hyperkinetic movement disorders.","volume":"17","author":"Jankovic","year":"2016","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"zoi210819r12","first-page":"99","article-title":"Antipsychotics side effects\u2019 influence on stigma of mental illness: focus group study results.","volume":"21","author":"Novak","year":"2009","journal-title":"Psychiatr Danub"},{"issue":"2","key":"zoi210819r13","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ncl.2020.01.004","article-title":"Treatment of tardive dyskinesia.","volume":"38","author":"Bashir","year":"2020","journal-title":"Neurol Clin"},{"key":"zoi210819r14","doi-asserted-by":"publisher","first-page":"422","DOI":"10.5334\/tohm.287","article-title":"Deutetrabenazine in tics associated with Tourette syndrome.","volume":"6","author":"Jankovic","year":"2016","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"4","key":"zoi210819r15","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/00004583-198907000-00015","article-title":"The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity.","volume":"28","author":"Leckman","year":"1989","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"zoi210819r16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/mds.v32.3","article-title":"Systematic review of severity scales and screening instruments for tics: critique and recommendations.","volume":"32","author":"Martino","year":"2017","journal-title":"Mov Disord"},{"issue":"1","key":"zoi210819r18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/0883073816670083","article-title":"The English version of the Gilles de la Tourette Syndrome\u2013Quality of Life Scale for Children and Adolescents (C&A-GTS-QOL).","volume":"32","author":"Su","year":"2017","journal-title":"J Child Neurol"},{"issue":"8","key":"zoi210819r19","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1007\/s10826-014-0038-x","article-title":"The Children\u2019s Depression Inventory in worldwide child development research: a reliability generalization study.","volume":"24","author":"Sun","year":"2015","journal-title":"J Child Fam Stud"},{"issue":"12","key":"zoi210819r20","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults.","volume":"168","author":"Posner","year":"2011","journal-title":"Am J Psychiatry"},{"issue":"2","key":"zoi210819r21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/15374410701279545","article-title":"Quality of life in youth with Tourette\u2019s syndrome and chronic tic disorder.","volume":"36","author":"Storch","year":"2007","journal-title":"J Clin Child Adolesc Psychol"},{"issue":"12","key":"zoi210819r22","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.jaac.2013.09.015","article-title":"Practice parameter for the assessment and treatment of children and adolescents with tic disorders.","volume":"52","author":"Murphy","year":"2013","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"zoi210819r24","first-page":"9","article-title":"Tetrabenazine in the treatment of Tourette syndrome.","volume":"5","author":"Kenney","year":"2007","journal-title":"J Ped Neurol"},{"issue":"2","key":"zoi210819r25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/WNF.0000000000000326","article-title":"Real-world experience with VMAT2 inhibitors.","volume":"42","author":"Niemann","year":"2019","journal-title":"Clin Neuropharmacol"},{"key":"zoi210819r27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-244X-8-3","article-title":"Evaluating dose response from flexible dose clinical trials.","volume":"8","author":"Lipkovich","year":"2008","journal-title":"BMC Psychiatry"},{"issue":"4","key":"zoi210819r28","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/pst.1498","article-title":"Analysis of dose-response in flexible dose titration clinical studies.","volume":"11","author":"Xu","year":"2012","journal-title":"Pharm Stat"},{"issue":"9","key":"zoi210819r29","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1089\/cap.2016.0026","article-title":"Randomized, double-blind, placebo-controlled trial demonstrates the efficacy and safety of oral aripiprazole for the treatment of Tourette\u2019s disorder in children and adolescents.","volume":"27","author":"Sallee","year":"2017","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"zoi210819r17","first-page":"550","volume-title":"Tourette\u2019s Syndrome and Tic Disorders","author":"Leckman","year":"1988"},{"key":"zoi210819r23","author":"Coffey","year":"2020"},{"key":"zoi210819r26","unstructured":"Neurocrine Biosciences. Neurocrine Biosciences announces topline data from phase IIb T-Force GOLD study demonstrating valbenazine did not meet primary endpoint in pediatric patients with Tourette syndrome. December 12, 2018. Accessed June 7, 2020. https:\/\/neurocrine.gcs-web.com\/news-releases\/news-release-details\/neurocrine-biosciences-announces-topline-data-phase-iib-t-force"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2784765\/jankovic_2021_oi_210819_1632849263.95.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T07:32:30Z","timestamp":1633591950000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2784765"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2021,10,5]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.28204","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,5]]}}}